wheas.blogg.se

Cover yasin cdr
Cover yasin cdr










cover yasin cdr

Suppiah, B., Vicknasingam, B., Singh, D., Narayanan, S.(2016) Traditional and non-traditional uses of Mitragynine (Kratom): A survey of the literature. Singh, D., Narayanan, S., Vicknasingam, B.(2016) Emerging drug use trends in Kelantan, Malaysia. Desrosiers, A., Chooi, W.T., Zaharim, N.M., Ahmad, I., Mohd Yasin, M.A., Syed Jaapar, S.Z., Schottenfeld, R.S., Vicknasingam, B., Chawarski, M.C.(2017) Changing trends in the use of kratom ( Mitragyna speciosa) in Southeast Asia. Singh, D., Narayanan, S., Vicknasingam, B., Corazza, O., Santacroce, R., Roman-Urrestarazu, A.(2017) Early initiation of amphetamine-type stimulants (ATS) use associated with lowered cognitive performance among individuals with co-occurring opioid and ATS use disorders in Malaysia. Chooi, W.T., Mohd Zaharim, N., Desrosiers, A., Ahmad, I., Yasin, M.A.M., Syed Jaapar, S.Z., Schottenfeld, R.S., Vicknasingam, B.K., Chawarski, M.C.(2017) Novel psychoactive substances-recent progress on neuropharmacological mechanisms of action for selected drugs. Hassan, Z., Bosch, O.G., Singh, D., Narayanan, S., Kasinather, B.V., Seifritz, E., Kornhuber, J., Quednow, B.B., Müller, C.P.

cover yasin cdr

(2018) Methadone complications amongst opioid-dependent patients in Malaysia: A case series.

cover yasin cdr

  • George, P., Vicknasingam, B., Thurairajasingam, S., Ramasamy, P., Mohd Yusof, H., Yasin, M.A.B.M., Shah, Z.U.B.S.
  • (2018) Evaluating the hematological and clinical-chemistry parameters of kratom ( Mitragyna speciosa) users in Malaysia.
  • Singh, D., Müller, C.P., Murugaiyah, V., Hamid, S.B.S., Vicknasingam, B.K., Avery, B., Chear, N.J.Y., Mansor, S.M.
  • (2018) Atomoxetine for amphetamine-type stimulant dependence during buprenorphine treatment: A randomized controlled trial.
  • Schottenfeld, R.S., Chawarski, M.C., Sofuoglu, M., Chooi, W.T., Zaharim, N.M., M Yasin, M.A., Ahmad, I., Syed Jaapar, S.Z., Vicknasingam, B.K.
  • (2018) Severity of pain and sleep problems during kratom ( Mitragyna speciosa Korth.) cessation among regular kratom users.
  • Singh, D., Narayanan, S., Vicknasingam, B.K., Prozialeck, W.C., Ramanathan, S., Zainal, H., Harun, S.N.
  • (2018) Assessment of gonadotropins and testosterone hormone levels in regular Mitragyna speciosa (Korth.) users.
  • Singh, D., Murugaiyah, V., Hamid, S.B.S., Kasinather, V., Chan, M.S.A., Ho, E.T.W., Grundmann, O., Chear, N.J.Y., Mansor, S.M.
  • Vicknasingam, B., Narayanan, S., Singh, D., Chawarski, M.
  • (2018) Severity of kratom ( Mitragyna speciosa Korth.) psychological withdrawal symptoms.
  • Singh, D., Narayanan, S., Müller, C.P., Swogger, M.T., Rahim, A.A., Leong Bin Abdullah M.F.I., Vicknasingam, B.K.
  • Pilot project to provide drug treatment for people who use drugs in Besut, Terengganu.
  • Drug counseling and abstinent-contingent take home buprenorphine in Malaysia.
  • Project health economic operational research (York model).
  • Developing international collaboration in addiction research between Universiti Sains Malaysia and Yale University.
  • A study of issues related to buprenorphine treatment in Malaysia.
  • Development of medical treatments for co-occuring opioid (heroin or morphine) and amphetamine-type stimulants (ATS) dependence (COATS).
  • In these trials, medications and behavioral interventions are provided and measured for its efficacy. An interesting emerging area of research is on recreational drug use (New Psychoactive Substances). I am also working with my colleagues to conduct several clinical trials among people who use opiates and amphetamines. Surveys to identify treatment barriers for people who use drugs and integration of substance abuse treatment with other medical services is also an area of my research. Behavioral surveys are conducted to identify treatment gaps for people who use drugs. My research interest is to understand and develop behavioral interventions for people who use drugs.












    Cover yasin cdr